
APUS
(NYSEAMERICAN)Apimeds Pharmaceuticals US, Inc.
$1.15-- (--)
Loading... - Market loading
Apimeds Pharmaceuticals US (APUS) Stock Analyst Forecast
Expert analyst consensus ratings, 12-month price targets, and professional investment recommendations.
No Analyst Ratings Available
There are currently no analyst ratings available for APUS in the last 90 days.
Analyst ratings will appear here once they become available from our data sources.